Telecoms, Media & Technology is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Reveal Biosensors is dedicated to advancing whole-body physiology monitoring applications with a new tissue oximeter. The signal is generated from a similar photonic light source used by pulse oximeters to detect blood oxygen levels, and that Fitbit, Apple and others use as the source for PPG heart rate information. Our sensor design uses different light wavelengths to detect real-time skin tissue responses.
This wearable sensor detects chemistry changes in tissue in response to tissue oxygen need vs. tissue oxygen delivery. We call this new biometric information a Tissue Oxygen Index (TOi). Skin tissue changes uniquely detected by the Reveal Tissue Oximeter are known to occur in several major health problems. Initial testing has shown potential value in detecting both insufficient, and excessive oxygen delivery to tissue. It has already demonstrated excellent sensitivity and responsiveness in screening for obstructive sleep apnea (OSA), adverse breathing conditions, and tracking the physiologic responses associated with exercise and recovery.
Reveal Biosensor’s Tissue Oximeter Sensor could make significant contributions to the general and medical wearables market by enabling new and more relevant physiology monitoring applications to better understand and track “digital health status”.
Our goal is to commercialize this sensor technology through licensee relationships to the Elite Sports, Fitness/Wellness, Worker Safety, and Healthcare markets.
Startup City - Booth # 30